Cloud-assisted body area networks: state-of-the-art and future challenges

Body area networks (BANs) are emerging as enabling technology for many human-centered application domains such as health-care, sport, fitness, wellness, ergonomics, emergency, safety, security, and sociality. A BAN, which basically consists of wireless wearable sensor nodes usually coordinated by a static or mobile device, is mainly exploited to monitor single assisted livings. Data generated by a BAN can be processed in real-time by the BAN coordinator and/or transmitted to a server-side for online/offline processing and long-term storing. A network of BANs worn by a community of people produces large amount of contextual data that require a scalable and efficient approach for elaboration and storage. Cloud computing can provide a flexible storage and processing infrastructure to perform both online and offline analysis of body sensor data streams. In this paper, we motivate the introduction of Cloud-assisted BANs along with the main challenges that need to be addressed for their development and management. The current state-of-the-art is overviewed and framed according to the main requirements for effective Cloud-assisted BAN architectures. Finally, relevant open research issues in terms of efficiency, scalability, security, interoperability, prototyping, dynamic deployment and management, are discussed

A toxicogenomic data space for system-level understanding and prediction of EDC-induced toxicity.

Endocrine disrupting compounds (EDCs) are a persistent threat to humans and wildlife due to their ability to interfere with endocrine signaling pathways. Inspired by previous work to improve chemical hazard identification through the use of toxicogenomics data, we developed a genomic-oriented data space for profiling the molecular activity of EDCs in an in silico manner, and for creating predictive models that identify and prioritize EDCs. Predictive models of EDCs, derived from gene expression data from rats (in vivo and in vitro primary hepatocytes) and humans (in vitro primary hepatocytes and HepG2), achieve testing accuracy greater than 90%. Negative test sets indicate that known safer chemicals are not predicted as EDCs. The rat in vivo-based classifiers achieve accuracy greater than 75% when tested for invitro to in vivoextrapolation. This study reveals key metabolic pathways and genes affected by EDCs together with a set of predictive models that utilize these pathways to prioritize EDCs in dose/time dependent manner and to predict EDCevokedmetabolic diseases

PTHrP on MCF-7 breast cancer cells: a growth factor or an antimitogenic peptide?

Letter to the Edito

Security and Privacy in Molecular Communication and Networking: Opportunities and Challenges

International audienceMolecular Communication (MC) is an emerging andpromising communication paradigm for several multi-disciplinarydomains like bio-medical, industry and military. Differently to thetraditional communication paradigm, the information is encodedon the molecules, that are then used as carriers of information.Novel approaches related to this new communication paradigmhave been proposed, mainly focusing on architectural aspects andcategorization of potential applications. So far, security and privacyaspects related to the molecular communication systems havenot been investigated at all and represent an open question thatneed to be addressed. The main motivation of this paper lies onproviding some first insights about security and privacy aspects ofMC systems, by highlighting the open issues and challenges andabove all by outlining some specific directions of potential solutions.Existing cryptographicmethods and security approaches arenot suitable for MC systems since do not consider the pecific issuesand challenges, that need ad-hoc solutions.We will discuss directionsin terms of potential solutions by trying to highlight themain advantages and potential drawbacks for each direction considered.We will try to answer to the main questions: 1) why thissolution can be exploited in the MC field to safeguard the systemand its reliability? 2) which are the main issues related to the specificapproach

Lower risk of death and cardiovascular events in patients with diabetes initiating glucagon-like peptide-1 receptor agonists or sodium-glucose cotransporter-2 inhibitors: A real-world study in two Italian cohorts

Aim: To examine the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 (SGLT2) inhibitors compared with other antihyperglycaemic agents (AHAs) in large and unselected populations of the Lombardy and Apulia regions in Italy. Materials and Methods: An observational cohort study of first-time users of GLP-1RAs, SGLT2 inhibitors or other AHAs was conducted from 2010 to 2018. Death and cardiovascular (CV) events were evaluated using conditional Cox models in propensity-score-matched populations. Adjusted hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated for each region and in a meta-analysis for pooled risks. Results: After propensity-score matching, the Lombardy cohort included 18 716 and 11 683 patients and the Apulia cohort 9772 and 6046 patients for the GLP-1RA and SGLT2 inhibitor groups, respectively. Use of GLP-1RAs was associated with lower rates of death (HR 0.61, CI 0.56-0.65, Lombardy; HR 0.63, CI 0.55-0.71, Apulia), cerebrovascular disease and ischaemic stroke (HR 0.70, CI 0.63-0.79; HR 0.72, CI 0.60-0.87, Lombardy), peripheral vascular disease (HR 0.72, CI 0.64-0.82, Lombardy; HR 0.80, CI 0.67-0.98, Apulia), and lower limb complications (HR 0.67, CI 0.56-0.81, Lombardy; HR 0.69, CI 0.51-0.93, Apulia). Compared with other AHAs, SGLT2 inhibitor use decreased the risk of death (HR 0.47, CI 0.40-0.54, Lombardy; HR 0.43, CI 0.32-0.57, Apulia), cerebrovascular disease (HR 0.75, CI 0.61-0.91, Lombardy; HR 0.72, CI 0.54-0.96, Apulia), and heart failure (HR 0.56, CI 0.46-0.70, Lombardy; HR 0.57, CI 0.42-0.77, Apulia). In the pooled cohorts, a reduction in heart failure was also observed with GLP-1RAs (HR 0.89, 95% CI 0.82-0.97). Serious adverse events were quite low in frequency. Conclusion: Our findings from real-world practice confirm the favourable effect of GLP-1RAs and SGLT2 inhibitors on death and CV outcomes across both regions consistently. Thus, these drug classes should be preferentially considered in a broad type 2 diabetes population beyond those with CV disease

Application of DEXiPM as a tool to co-design pome fruit systems towards sustainability

The design of fruit production systems considering the latest innovations is a real challenge. Before being tested in an experimental station or in real farm conditions, the global sustainability of these newly designed orchards needs to be evaluated. Based on the DEXiPM® model, the DEXiPM-pomefruit tool has been designed to make an ex ante assessment of the sustainability of innovative orchard systems. This model is based on a decision tree breaking the decisional problems of sustainability assessment into simpler units, referring to the economic, social and environmental dimensions of sustainability. Based on two case studies, we present here the steps and thought process of our group to improve fruit production systems towards innovative and integrated production systems. DEXiPM-pomefruit tool has been tested on apple and pear production systems in the frame of a working group of European researchers. It proved to be sufficiently reliable to select the most promising innovations in a given context. DEXiPM-pomefruit was also used as a dashboard to determine strengths and weaknesses of the tested production systems and therefore to identify improvements

Internet of Things for Sustainable Community Development: Introduction and Overview

The two-third of the city-dwelling world population by 2050 poses numerous global challenges in the infrastructure and natural resource management domains (e.g., water and food scarcity, increasing global temperatures, and energy issues). The IoT with integrated sensing and communication capabilities has the strong potential for the robust, sustainable, and informed resource management in the urban and rural communities. In this chapter, the vital concepts of sustainable community development are discussed. The IoT and sustainability interactions are explained with emphasis on Sustainable Development Goals (SDGs) and communication technologies. Moreover, IoT opportunities and challenges are discussed in the context of sustainable community development

Surface PEGylation suppresses pulmonary effects of CuO in allergen-induced lung inflammation

BACKGROUND: Copper oxide (CuO) nanomaterials are used in a wide range of industrial and commercial applications. These materials can be hazardous, especially if they are inhaled. As a result, the pulmonary effects of CuO nanomaterials have been studied in healthy subjects but limited knowledge exists today about their effects on lungs with allergic airway inflammation (AAI). The objective of this study was to investigate how pristine CuO modulates allergic lung inflammation and whether surface modifications can influence its reactivity. CuO and its carboxylated (CuO COOH), methylaminated (CuO NH3) and PEGylated (CuO PEG) derivatives were administered here on four consecutive days via oropharyngeal aspiration in a mouse model of AAI. Standard genome-wide gene expression profiling as well as conventional histopathological and immunological methods were used to investigate the modulatory effects of the nanomaterials on both healthy and compromised immune system. RESULTS: Our data demonstrates that although CuO materials did not considerably influence hallmarks of allergic airway inflammation, the materials exacerbated the existing lung inflammation by eliciting dramatic pulmonary neutrophilia. Transcriptomic analysis showed that CuO, CuO COOH and CuO NH3 commonly enriched neutrophil-related biological processes, especially in healthy mice. In sharp contrast, CuO PEG had a significantly lower potential in triggering changes in lungs of healthy and allergic mice revealing that surface PEGylation suppresses the effects triggered by the pristine material. CONCLUSIONS: CuO as well as its functionalized forms worsen allergic airway inflammation by causing neutrophilia in the lungs, however, our results also show that surface PEGylation can be a promising approach for inhibiting the effects of pristine CuO. Our study provides information for health and safety assessment of modified CuO materials, and it can be useful in the development of nanomedical applications